In an odd example that should serve as a warning to thousands of new parents, a baby girl got a “micropenis” after lying on her father’s chest, according to medical professionals.
In one instance, a baby girl lay down on her father’s naked chest, according to Swedish medical professionals. Skin-to-skin contact is a crucial aspect of newborn care that offers numerous health advantages.
In this instance, though, the father was utilizing a testosterone gel product, which is a synthetic form of the male sex hormone. This medication is frequently administered to men to assist them in dealing with the “manopause,” which is a term used to describe low energy and lagging sexual drive as men age.
The father unintentionally exposed his daughter to excessively high testosterone levels by placing her on his naked chest.
Her genitalia underwent significant alterations as a result, with her labia sealing over to resemble a male scrotum and her clitoris getting longer, like a tiny penis.
This was referred to as a “micropenis” by local media.
The girl, who was now 10 months old, was brought to the doctor by her worried parents, who promptly used blood tests to determine the cause of the issue.
Fortunately, the girl’s genitalia decreased once the man ceased unintentionally exposing her to his testosterone gel.
The event, which happened eight years ago, was one of six comparable incidents that Professor Jovanna Dahlgren, a pediatric endocrinology specialist at Sahlgrenska University Hospital in Gothenburg, included in her warning.
As more and more parents take hormone treatments, Professor Dahlgren said she wants to bring attention to the risks these treatments pose to children in an interview with the Swedish newspaper Göteborgs-Posten.
“I don’t think people always understand how potent these treatments are,” she said. “The parents become completely desperate when they understand what has happened.”
She also mentioned another instance in which a 10-year-old child who was exposed to a feminine s£x hormone treatment his mother was receiving developed breasts.
The caution comes as the testosterone replacement therapy (TRT) sector is flourishing and several private companies are selling the hormone to men.